• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者的百分位数基准:以健康评估问卷作为质量指标(QI)

Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI).

作者信息

Krishnan Eswar, Tugwell Peter, Fries James F

机构信息

Clinical Research Center of Reading, West Reading, PA, USA.

出版信息

Arthritis Res Ther. 2004;6(6):R505-13. doi: 10.1186/ar1220. Epub 2004 Sep 14.

DOI:10.1186/ar1220
PMID:15535828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1064863/
Abstract

Physicians are in need of a simple objective, standardized tool to compare their patients with rheumatoid arthritis, as a group and individually, with national standards. The Disability Index of the Health Assessment Questionnaire (HAQ-DI) is a simple, robust tool that can fulfill these needs. However, use of this tool as a quality indicator (QI) is hampered by the unavailability of national reference values or benchmarks based on large, multicentric, heterogenous longitudinal patient cohorts. We utilized the 20-year longitudinal prospective data from 11 data banks of Arthritis Rheumatism and Aging Medical Information to calculate reference values for HAQ-DI. Overall, 6436 patients with rheumatoid arthritis were longitudinally followed for 32,324 person-years over the 20 years from 1981 to 2000. There were 64,647 HAQ-DI measurements, with an average of 19 measurements per person. Overall, 75% of patients were women and 89% were Caucasian; the median baseline age was 58.4 years and the median baseline HAQ-DI was 1.13. Few patients were treated with biologics. The HAQ-DI values had a Gaussian distribution except for the approximately 10% of observations showing no disability. Percentile benchmarks allow disability outcomes to be compared and contrasted between different patient populations. Reference values for the HAQ-DI, presented here numerically and graphically, can be used in clinical practice as a QI measure to track functional disability outcomes and to measure response to therapy, and by arthritis patients in self-management programs.

摘要

医生需要一种简单、客观、标准化的工具,以便将他们的类风湿关节炎患者群体和个体与国家标准进行比较。健康评估问卷残疾指数(HAQ-DI)是一种能够满足这些需求的简单而可靠的工具。然而,由于缺乏基于大型、多中心、异质性纵向患者队列的全国参考值或基准,该工具作为质量指标(QI)的使用受到了阻碍。我们利用来自关节炎、风湿病和衰老医学信息11个数据库的20年纵向前瞻性数据来计算HAQ-DI的参考值。总体而言,从1981年到2000年的20年中,对6436例类风湿关节炎患者进行了32324人年的纵向随访。共进行了64647次HAQ-DI测量,平均每人19次。总体而言,75%的患者为女性,89%为白种人;基线年龄中位数为58.4岁,基线HAQ-DI中位数为1.13。很少有患者接受生物制剂治疗。除了约10%的观察结果显示无残疾外,HAQ-DI值呈高斯分布。百分位数基准允许在不同患者群体之间比较和对比残疾结果。本文以数字和图形形式呈现的HAQ-DI参考值,可在临床实践中用作QI指标,以跟踪功能残疾结果并衡量治疗反应,也可供关节炎患者在自我管理项目中使用。

相似文献

1
Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI).类风湿关节炎患者的百分位数基准:以健康评估问卷作为质量指标(QI)
Arthritis Res Ther. 2004;6(6):R505-13. doi: 10.1186/ar1220. Epub 2004 Sep 14.
2
Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?类风湿关节炎临床缓解患者的关节损伤进展:生物制剂比合成抗风湿药物效果更好吗?
J Rheumatol. 2014 Aug;41(8):1576-82. doi: 10.3899/jrheum.130767. Epub 2014 Jul 15.
3
The methotrexate therapeutic response in rheumatoid arthritis.甲氨蝶呤在类风湿关节炎中的治疗反应
J Rheumatol. 2002 Oct;29(10):2084-91.
4
Using Rasch analysis to compare the psychometric properties of the Short Form 36 physical function score and the Health Assessment Questionnaire disability index in patients with psoriatic arthritis and rheumatoid arthritis.运用拉施分析比较银屑病关节炎和类风湿关节炎患者的简明健康状况调查量表身体功能评分与健康评估问卷残疾指数的心理测量学特性。
Arthritis Rheum. 2007 Jun 15;57(5):723-9. doi: 10.1002/art.22770.
5
Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts.早期类风湿关节炎中健康评估问卷残疾进展:两个起始队列的系统评价与分析
Semin Arthritis Rheum. 2014 Oct;44(2):131-44. doi: 10.1016/j.semarthrit.2014.05.003. Epub 2014 May 9.
6
Determinants associated with work participation in patients with established rheumatoid arthritis taking tumor necrosis factor inhibitors.与正在服用肿瘤坏死因子抑制剂的类风湿关节炎患者工作参与度相关的决定因素。
J Rheumatol. 2014 Jul;41(7):1263-9. doi: 10.3899/jrheum.130878. Epub 2014 May 15.
7
Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.类风湿关节炎患者的医生和患者整体评估随时间的比较:来自 RADIUS 队列的回顾性分析。
J Clin Rheumatol. 2013 Sep;19(6):317-23. doi: 10.1097/RHU.0b013e3182a2164f.
8
Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population.类风湿关节炎患者与普通人群相比,五年内健康评估问卷残疾评分的变化。
Arthritis Rheum. 2006 Oct;54(10):3113-8. doi: 10.1002/art.22130.
9
Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain.采用 HAQ-DI 估算西班牙类风湿关节炎患者的 HUI-3 和 EQ-5D 效用值。
Value Health. 2011 Jan;14(1):192-200. doi: 10.1016/j.jval.2010.11.001.
10
Trends in Functional Disability and Determinants of Clinically Meaningful Change Over Time in Hispanic Patients With Rheumatoid Arthritis in the US.美国西班牙裔类风湿关节炎患者功能残疾的趋势及随时间临床意义变化的决定因素
Arthritis Care Res (Hoboken). 2017 Feb;69(2):294-298. doi: 10.1002/acr.22924.

引用本文的文献

1
Functional limitations of people with rheumatoid arthritis or axial spondyloarthritis and severe functional disability: a cross-sectional descriptive study.类风湿关节炎或中轴型脊柱关节炎患者的功能障碍及严重功能残疾:一项横断面描述性研究。
Rheumatol Int. 2024 Jan;44(1):129-143. doi: 10.1007/s00296-023-05487-z. Epub 2023 Nov 25.
2
Optimal designs for health risk assessments using fractional polynomial models.使用分数多项式模型进行健康风险评估的优化设计。
Stoch Environ Res Risk Assess. 2022 Sep;36(9):2695-2710. doi: 10.1007/s00477-021-02155-1. Epub 2022 Jan 5.
3
Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis.

本文引用的文献

1
Attrition bias in rheumatoid arthritis databanks: a case study of 6346 patients in 11 databanks and 65,649 administrations of the Health Assessment Questionnaire.类风湿性关节炎数据库中的失访偏倚:一项对11个数据库中6346例患者及65649次健康评估问卷管理情况的案例研究。
J Rheumatol. 2004 Jul;31(7):1320-6.
2
Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population.健康评估问卷残疾指数的标准值:普通人群残疾情况的基准
Arthritis Rheum. 2004 Mar;50(3):953-60. doi: 10.1002/art.20048.
3
Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients.
关注性别:类风湿关节炎管理中我们需要了解的内容。
J Pers Med. 2022 Mar 20;12(3):499. doi: 10.3390/jpm12030499.
4
Benefit-Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis.乌帕替尼与阿达木单抗治疗中重度类风湿关节炎患者的获益-风险分析
Rheumatol Ther. 2022 Feb;9(1):191-206. doi: 10.1007/s40744-021-00399-5. Epub 2021 Nov 23.
5
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?中枢敏化是慢性炎症性关节炎患者功能残疾的重要决定因素吗?
Ther Adv Musculoskelet Dis. 2021 Feb 15;13:1759720X21993252. doi: 10.1177/1759720X21993252. eCollection 2021.
6
Development and External Validity of a Short-Form Version of the INICIARE Scale to Classify Nursing Care Dependency Level in Acute Hospitals.开发并验证 INICIARE 量表的短版本,以在急性医院中对护理依赖水平进行分类。
Int J Environ Res Public Health. 2020 Nov 17;17(22):8511. doi: 10.3390/ijerph17228511.
7
Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis.静脉注射或皮下注射托珠单抗对类风湿关节炎患者报告的生活质量结果的影响。
RMD Open. 2018 Jun 17;4(1):e000602. doi: 10.1136/rmdopen-2017-000602. eCollection 2018.
8
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis.患者报告的结果来自于一项 sarilumab 单药治疗与 adalimumab 单药治疗类风湿关节炎患者的随机 III 期临床试验。
Arthritis Res Ther. 2018 Jun 19;20(1):129. doi: 10.1186/s13075-018-1614-z.
9
Impact of tocilizumab monotherapy on patient-reported outcomes in patients with rheumatoid arthritis from two randomised controlled trials.托珠单抗单药治疗对两项随机对照试验中类风湿关节炎患者报告结局的影响。
RMD Open. 2017 Sep 14;3(2):e000496. doi: 10.1136/rmdopen-2017-000496. eCollection 2017.
10
Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study.类风湿关节炎患者疲劳的季节性变化:一项纵向研究。
BMC Musculoskelet Disord. 2016 Feb 4;17:59. doi: 10.1186/s12891-016-0911-4.
1977年至1998年类风湿关节炎患者长期功能残疾的减少:对3035例患者的纵向研究
Am J Med. 2003 Oct 1;115(5):371-6. doi: 10.1016/s0002-9343(03)00397-8.
4
1958 Revision of diagnostic criteria for rheumatoid arthritis.1958年类风湿关节炎诊断标准修订版。
Bull Rheum Dis. 1958 Dec;9(4):175-6.
5
Functional disability in rheumatoid arthritis patients compared with a community population in Finland.类风湿关节炎患者与芬兰社区人群相比的功能残疾情况。
Arthritis Rheum. 2003 Jan;48(1):59-63. doi: 10.1002/art.10731.
6
The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.斯坦福健康评估问卷:对其历史、问题、进展及文献记录的综述
J Rheumatol. 2003 Jan;30(1):167-78.
7
Benchmarking and the percentile assessment of RA: adding a new dimension to rheumatic disease measurement.类风湿关节炎的基准化和百分位数评估:为风湿病测量增添新维度。
Ann Rheum Dis. 2001 Nov;60(11):994-5. doi: 10.1136/ard.60.11.994.
8
Benchmarking: the five year outcome of rheumatoid arthritis assessed using a pain score, the Health Assessment Questionnaire, and the Short Form-36 (SF-36) in a community and a clinic based sample.基准评估:在一个基于社区和诊所的样本中,使用疼痛评分、健康评估问卷和简明健康调查问卷(SF-36)对类风湿性关节炎的五年结局进行评估。
Ann Rheum Dis. 2001 Oct;60(10):956-61. doi: 10.1136/ard.60.10.956.
9
Usefulness of the HAQ in the clinic.健康评估问卷(HAQ)在临床中的实用性。
Ann Rheum Dis. 2001 Aug;60(8):811. doi: 10.1136/ard.60.8.811.
10
Arthritis, Rheumatism and Aging Medical Information System Post-Marketing Surveillance Program.关节炎、风湿病与衰老医学信息系统上市后监测项目
J Rheumatol. 2001 May;28(5):1174-9.